Drug
Margetuximab Margetuximab
Margetuximab Margetuximab: highest development phase Phase 1, developed by Zai Lab. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Zai Lab
Trials
| Drug | Phase | Indication |
|---|---|---|
| Margetuximab Margetuximab-IV NCT04398108 | Phase 1 | HER2 Positive Metastatic Breast Cancer |
Latest
No recent events.
Follow Margetuximab Margetuximab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.